Curation
PascalFrancis
Racine
Curation
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease

Identifieur interne : 001493 ( PascalFrancis/Curation ); précédent : 001492; suivant : 001494

A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease

Auteurs : A.-M. Ferrandez [France] ; O. Blin

Source :

RBID : Pascal:92-0148243

Descripteurs français

English descriptors

Abstract

The aims of the present study were to analyze how L-Dopa allows parkinsonian patients to increase their gait velocity and to compare theseL-Dopa-induced modifications with those achieved by 'consciously' attempting to walk as fast as possible (intentional modulations). The 'intentional modulations' of velocity were also compared with those of healthy elderly subjects. The results showed that parkinsonian patients walked more slowly, with shorter strides and shorter durations of swing phase, and longer durations of stance and double support phases, although no differences were observed for cycle duration
pA  
A01 01  1    @0 0166-4328
A02 01      @0 BBREDI
A03   1    @0 Behav. brain res.
A05       @2 45
A06       @2 2
A08 01  1  ENG  @1 A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease
A11 01  1    @1 FERRANDEZ (A.-M.)
A11 02  1    @1 BLIN (O.)
A14 01      @1 CNRS Univ. Aix-Marseille II, fac. médecine, IBHOP @2 Marseille 13388 @3 FRA
A14 02      @1 CHU TImone, clin. maladies neuro-musculaires appareil locomoteur @2 Marseille @3 FRA @Z 2 aut.
A20       @1 177-183
A21       @1 1991
A23 01      @0 ENG
A24 01      @0 eng
A43 01      @1 INIST @2 18271 @5 354000022054910080
A44       @0 0000
A45       @0 38 ref.
A47 01  1    @0 92-0148243
A60       @1 P
A61       @0 A
A64   1    @0 Behavioural brain research
A66 01      @0 NLD
C01 01    ENG  @0 The aims of the present study were to analyze how L-Dopa allows parkinsonian patients to increase their gait velocity and to compare theseL-Dopa-induced modifications with those achieved by 'consciously' attempting to walk as fast as possible (intentional modulations). The 'intentional modulations' of velocity were also compared with those of healthy elderly subjects. The results showed that parkinsonian patients walked more slowly, with shorter strides and shorter durations of swing phase, and longer durations of stance and double support phases, although no differences were observed for cycle duration
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Parkinson maladie
C03 01  X  ENG  @0 Parkinson disease
C03 01  X  SPA  @0 Parkinson enfermedad
C03 02  X  FRE  @0 Dopa @2 NK @2 FR
C03 02  X  ENG  @0 Dopa @2 NK @2 FR
C03 02  X  SPA  @0 Dopa @2 NK @2 FR
C03 03  X  FRE  @0 Locomotion
C03 03  X  ENG  @0 Locomotion
C03 03  X  SPA  @0 Locomoción
C03 04  X  FRE  @0 Allure
C03 04  X  ENG  @0 Gait
C03 04  X  SPA  @0 Marcha
C03 05  X  FRE  @0 Noyau gris central
C03 05  X  ENG  @0 Basal ganglion
C03 05  X  SPA  @0 Núcleo basal
C03 06  X  FRE  @0 Sénescence
C03 06  X  ENG  @0 Senescence
C03 06  X  SPA  @0 Senescencia
C03 07  X  FRE  @0 Homme
C03 07  X  ENG  @0 Human
C03 07  X  SPA  @0 Hombre
C07 01  X  FRE  @0 Maladie dégénérative
C07 01  X  ENG  @0 Degenerative disease
C07 01  X  SPA  @0 Enfermedad degenerativa
C07 02  X  FRE  @0 Motricité
C07 02  X  ENG  @0 Motricity
C07 02  X  SPA  @0 Motricidad
C07 03  X  FRE  @0 Système nerveux central
C07 03  X  ENG  @0 Central nervous system
C07 03  X  SPA  @0 Sistema nervioso central
N21       @1 149

Links toward previous steps (curation, corpus...)

Links to Exploration step

Pascal:92-0148243

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease</title>
<author>
<name sortKey="Ferrandez, A M" sort="Ferrandez, A M" uniqKey="Ferrandez A" first="A.-M." last="Ferrandez">A.-M. Ferrandez</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CNRS Univ. Aix-Marseille II, fac. médecine, IBHOP</s1>
<s2>Marseille 13388</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Blin, O" sort="Blin, O" uniqKey="Blin O" first="O." last="Blin">O. Blin</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">92-0148243</idno>
<date when="1991">1991</date>
<idno type="stanalyst">PASCAL 92-0148243 INIST</idno>
<idno type="RBID">Pascal:92-0148243</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001B58</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001493</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease</title>
<author>
<name sortKey="Ferrandez, A M" sort="Ferrandez, A M" uniqKey="Ferrandez A" first="A.-M." last="Ferrandez">A.-M. Ferrandez</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CNRS Univ. Aix-Marseille II, fac. médecine, IBHOP</s1>
<s2>Marseille 13388</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Blin, O" sort="Blin, O" uniqKey="Blin O" first="O." last="Blin">O. Blin</name>
</author>
</analytic>
<series>
<title level="j" type="main">Behavioural brain research</title>
<title level="j" type="abbreviated">Behav. brain res.</title>
<idno type="ISSN">0166-4328</idno>
<imprint>
<date when="1991">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Behavioural brain research</title>
<title level="j" type="abbreviated">Behav. brain res.</title>
<idno type="ISSN">0166-4328</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Basal ganglion</term>
<term>Dopa</term>
<term>Gait</term>
<term>Human</term>
<term>Locomotion</term>
<term>Parkinson disease</term>
<term>Senescence</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Dopa</term>
<term>Locomotion</term>
<term>Allure</term>
<term>Noyau gris central</term>
<term>Sénescence</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The aims of the present study were to analyze how L-Dopa allows parkinsonian patients to increase their gait velocity and to compare theseL-Dopa-induced modifications with those achieved by 'consciously' attempting to walk as fast as possible (intentional modulations). The 'intentional modulations' of velocity were also compared with those of healthy elderly subjects. The results showed that parkinsonian patients walked more slowly, with shorter strides and shorter durations of swing phase, and longer durations of stance and double support phases, although no differences were observed for cycle duration</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0166-4328</s0>
</fA01>
<fA02 i1="01">
<s0>BBREDI</s0>
</fA02>
<fA03 i2="1">
<s0>Behav. brain res.</s0>
</fA03>
<fA05>
<s2>45</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>FERRANDEZ (A.-M.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>BLIN (O.)</s1>
</fA11>
<fA14 i1="01">
<s1>CNRS Univ. Aix-Marseille II, fac. médecine, IBHOP</s1>
<s2>Marseille 13388</s2>
<s3>FRA</s3>
</fA14>
<fA14 i1="02">
<s1>CHU TImone, clin. maladies neuro-musculaires appareil locomoteur</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>177-183</s1>
</fA20>
<fA21>
<s1>1991</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA24 i1="01">
<s0>eng</s0>
</fA24>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18271</s2>
<s5>354000022054910080</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>92-0148243</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Behavioural brain research</s0>
</fA64>
<fA66 i1="01">
<s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The aims of the present study were to analyze how L-Dopa allows parkinsonian patients to increase their gait velocity and to compare theseL-Dopa-induced modifications with those achieved by 'consciously' attempting to walk as fast as possible (intentional modulations). The 'intentional modulations' of velocity were also compared with those of healthy elderly subjects. The results showed that parkinsonian patients walked more slowly, with shorter strides and shorter durations of swing phase, and longer durations of stance and double support phases, although no differences were observed for cycle duration</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Locomotion</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Locomotion</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Locomoción</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Allure</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Gait</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Marcha</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Noyau gris central</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Basal ganglion</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Núcleo basal</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Sénescence</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Senescence</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Senescencia</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Degenerative disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Motricité</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Motricity</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Motricidad</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux central</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Central nervous system</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso central</s0>
</fC07>
<fN21>
<s1>149</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001493 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001493 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:92-0148243
   |texte=   A comparison between the effect of intentional modulations and the action of L-Dopa on gait in Parkinsons's disease
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024